Articles published by GlobeNewswire
Commerce to Announce Fourth Quarter 2025 and Full Year 2025 Financial Results on February 12th, 2026
January 13, 2026
From Commerce.com, Inc.
Via GlobeNewswire
Tickers
CMRC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
NKTR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Duluth Holdings Inc. - DLTH
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
DLTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
RXST
O-I Glass Announces Full Year and Fourth Quarter 2025 Earnings Conference Call and Webcast
January 13, 2026
Via GlobeNewswire
Tickers
OI
Voting Rights and Shares Capital of the Company
January 13, 2026
From Nanobiotix S.A.
Via GlobeNewswire
Tickers
NBTX
UniFirst Declares Regular Cash Dividends
January 13, 2026
From UniFirst Corporation
Via GlobeNewswire
Tickers
UNF
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. - NUAI
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
NUAI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
MREO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investorsof Bgin Blockchain Limited - BGIN
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
BGIN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. - NTNX
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
NTNX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
ORGO
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
January 13, 2026
Via GlobeNewswire
Tickers
FHTX
Crane NXT Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Earnings Call
January 13, 2026
From Crane NXT
Via GlobeNewswire
Tickers
CXT
Via GlobeNewswire
Tickers
MDLZ
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 13, 2026
Via GlobeNewswire
Tickers
BBOT
America’s Car-Mart Advances SG&A Cost Control Strategy With Phase 2 Store Consolidations
January 13, 2026
Via GlobeNewswire
Tickers
CRMT
Parsons to Announce Fourth Quarter 2025 and Fiscal Year 2025 Financial Results on February 11, 2026
January 13, 2026
Via GlobeNewswire
Tickers
PSN
Runway Growth Finance Corp. Provides Fourth Quarter 2025 Portfolio and Transaction Update
January 13, 2026
Via GlobeNewswire
Tickers
RWAY
From Grocery Outlet, Inc.
Via GlobeNewswire
Tickers
GO
Ingredion to Release 2025 Fourth Quarter and Full Year Financial Results On February 3, 2026
January 13, 2026
Via GlobeNewswire
Tickers
INGR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
TIL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.